Tailoi Chan-Ling

Hannah C. Leeson^1,2, 

Tailoi Chan-Ling^3,4, 

Michael D. Lovelace^3,5,6, 

Jeremy D. Brownlie⁷, 

Michael W. Weible II^*,1,4,7, 

Ben J. Gu^*,8 

¹Griffith Institute for Drug Discovery, Griffith University, 

²Australian Institute for Bioengineering and Nanotechnology, University of Queensland, 

³Discipline of Anatomy and Histology, School of Medical Science, University of Sydney, 

⁴Bosch Institute, University of Sydney, 

⁵Applied Neurosciences Program, Peter Duncan Neurosciences Research Unit, St. Vincent's Centre for Applied Medical Research, 

⁶School of Medical Sciences, The University of New South Wales (UNSW) Medicine, Sydney, New South Wales, 

⁷School of Environment and Science, Griffith University, Brisbane, Queensland, 

⁸Florey Institute of Neuroscience and Mental Health, University of Melbourne